Sabra Healthcare REIT, Inc. (NASDAQ:SBRA) was upgraded by equities researchers at ValuEngine from a “hold” rating to a “buy” rating in a research note issued on Monday.

Several other research analysts also recently commented on the company. BidaskClub raised Sabra Healthcare REIT from a “hold” rating to a “buy” rating in a research report on Tuesday, June 27th. Mizuho reiterated a “neutral” rating on shares of Sabra Healthcare REIT in a report on Wednesday, June 28th. Stifel Nicolaus reissued a “hold” rating and issued a $26.00 price objective on shares of Sabra Healthcare REIT in a research report on Friday, July 28th. Zacks Investment Research raised Sabra Healthcare REIT from a “sell” rating to a “hold” rating in a research report on Wednesday, August 2nd. Finally, Jefferies Group LLC restated a “hold” rating and issued a $25.00 price objective (down previously from $28.00) on shares of Sabra Healthcare REIT in a research note on Sunday, July 9th. Two analysts have rated the stock with a sell rating, four have issued a hold rating and five have given a buy rating to the company’s stock. Sabra Healthcare REIT has an average rating of “Hold” and an average target price of $24.89.

Shares of Sabra Healthcare REIT (SBRA) opened at 21.82 on Monday. The stock has a 50 day moving average of $22.12 and a 200-day moving average of $24.23. Sabra Healthcare REIT has a 52 week low of $19.30 and a 52 week high of $29.10.

WARNING: “ValuEngine Upgrades Sabra Healthcare REIT, Inc. (SBRA) to Buy” was reported by Watch List News and is the property of of Watch List News. If you are accessing this piece on another website, it was illegally copied and republished in violation of U.S. and international trademark & copyright law. The legal version of this piece can be read at https://www.watchlistnews.com/valuengine-upgrades-sabra-healthcare-reit-inc-sbra-to-buy/1606968.html.

Several hedge funds and other institutional investors have recently modified their holdings of the stock. Phocas Financial Corp. lifted its position in Sabra Healthcare REIT by 4.7% in the second quarter. Phocas Financial Corp. now owns 212,756 shares of the real estate investment trust’s stock worth $5,127,000 after purchasing an additional 9,470 shares during the period. Cetera Investment Advisers acquired a new stake in Sabra Healthcare REIT during the second quarter worth $505,000. Wasatch Advisors Inc. boosted its stake in Sabra Healthcare REIT by 14.5% during the second quarter. Wasatch Advisors Inc. now owns 570,029 shares of the real estate investment trust’s stock worth $13,738,000 after buying an additional 72,125 shares in the last quarter. Koch Industries Inc. acquired a new stake in Sabra Healthcare REIT during the second quarter worth $739,000. Finally, Piedmont Investment Advisors LLC acquired a new stake in Sabra Healthcare REIT during the second quarter worth $340,000. Institutional investors and hedge funds own 99.26% of the company’s stock.

About Sabra Healthcare REIT

Sabra Health Care REIT, Inc is a real estate investment trust. The Company, through its subsidiaries, owns and invests in real estate serving the healthcare industry. The Company’s segment includes investments in healthcare-related real estate properties. The Company’s primary business consists of acquiring, financing and owning real estate property to be leased to third-party tenants in the healthcare sector.

Analyst Recommendations for Sabra Healthcare REIT (NASDAQ:SBRA)

Receive News & Ratings for Sabra Healthcare REIT Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sabra Healthcare REIT Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.